891 REAL WORD EXPERIENCE WITH TRIPLE THERAPY FOR HCV GT1 PATIENTS IN DIFFICULT TO TREAT PATIENTS: SEVERE ADVERSE EVENTS AND HIGH RATES OF VIROLOGICAL BREAK-THROUGH | Publicación